MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11320%2F17%3A10364386" target="_blank" >RIV/00216208:11320/17:10364386 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/17:10364386 RIV/00064165:_____/17:10364386
Result on the web
<a href="http://dx.doi.org/10.1038/bcj.2017.63" target="_blank" >http://dx.doi.org/10.1038/bcj.2017.63</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/bcj.2017.63" target="_blank" >10.1038/bcj.2017.63</a>

Result language
angličtina
Original language name
MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
Original language description
Chronic lymphocytic leukemia (CLL) is a slowly developing progression-prone disease. MicroRNAs miR-155 and miR-150 are small inhibitors of gene expression in B-cells that were previously connected to the pathogenesis of CLL. We herein evaluated relationship of miR-155/miR-150 network with clinical and routine laboratory parameters of the CLL patient cohort utilizing multivariate analyses and found its association with overall survival and progression of CLL.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)